Ronny Hashmonay has over 20 years of hands on international experience in the healthcare and pharmaceutical industry and across multiple functions and disease areas. He has worked with major Pharmaceutical companies such as Pfizer, Johnson & Johnson and Novartis in global Vice President level positions, Commercial, Medical Affairs, Drug development and more recently health tech/digital health as Chief Digital Officer at Novartis US.
In 2023, Hashmonay co-founded an innovative Venture Capital firm, P74 Ventures, which is uniquely focused on both founding and investing in technology companies that drive innovation and business model transformation within the $1.5 trillion life sciences industry. P74 Ventures drives investment in the enabling technologies that drive the business & operations of pharma.
Hashmonay is a MD graduated from the Israeli Institute of Technology (Technion) with honors, and serves on Board of Apothems, a healthcare investment firm.